2-28412111-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_005253.4(FOSL2):c.644C>T(p.Ser215Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000676 in 1,605,980 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_005253.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FOSL2 | NM_005253.4 | c.644C>T | p.Ser215Leu | missense_variant | 4/4 | ENST00000264716.9 | NP_005244.1 | |
FOSL2 | XM_006711976.4 | c.695C>T | p.Ser232Leu | missense_variant | 4/4 | XP_006712039.1 | ||
FOSL2 | XM_006711977.4 | c.578C>T | p.Ser193Leu | missense_variant | 4/4 | XP_006712040.1 | ||
FOSL2 | XM_005264231.5 | c.*129C>T | 3_prime_UTR_variant | 5/5 | XP_005264288.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FOSL2 | ENST00000264716.9 | c.644C>T | p.Ser215Leu | missense_variant | 4/4 | 1 | NM_005253.4 | ENSP00000264716.4 | ||
FOSL2 | ENST00000379619.5 | c.620C>T | p.Ser207Leu | missense_variant | 4/4 | 1 | ENSP00000368939.1 | |||
FOSL2 | ENST00000436647.1 | c.527C>T | p.Ser176Leu | missense_variant | 4/4 | 2 | ENSP00000396497.1 |
Frequencies
GnomAD3 genomes AF: 0.000263 AC: 40AN: 152068Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000265 AC: 64AN: 241218Hom.: 0 AF XY: 0.000289 AC XY: 38AN XY: 131424
GnomAD4 exome AF: 0.000719 AC: 1046AN: 1453912Hom.: 0 Cov.: 33 AF XY: 0.000712 AC XY: 515AN XY: 723392
GnomAD4 genome AF: 0.000263 AC: 40AN: 152068Hom.: 0 Cov.: 32 AF XY: 0.000135 AC XY: 10AN XY: 74270
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 12, 2023 | The c.644C>T (p.S215L) alteration is located in exon 4 (coding exon 4) of the FOSL2 gene. This alteration results from a C to T substitution at nucleotide position 644, causing the serine (S) at amino acid position 215 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at